China Resources Pharmaceutical Group Ltd. (3320.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 27.96B |
| Enterprise Value | 115.2B |
| P/E Ratio | 5.67 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 0.09 |
| Price/Book Ratio | 0.44 |
| Enterprise/Revenue | 0.36 |
| Enterprise/EBITDA | 6.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.02 |
| Operating Margin | 0.04 |
| Return On Assets | 0.01 |
| Return On Equity | 0.08 |
| Revenue | 300.01B |
| Revenue/Share | 48.79 |
| Gross Profit | 49.53B |
| EBITDA | 17.7B |
| Net Income | 4.5B |
| Diluted EPS | 0.72 |
| Total Cash | 44.03B |
| Total Cash/Share | 7.01 |
| Total Debt | 114.17B |
| Total Debt/Equity | 1.87 |
| Current Ratio | 1.43 |
| Book Value Per Share | 21.95 |
| 52-Week Change | -14.49 |
| 52-Week High | 6.53 |
| 52-Week Low | 4.22 |
| Moving Average 50 Days | 4.69 |
| Moving Average 200 Days | 4.83 |
| Average Volume | 8.71M |
| Shares Outstanding | 6.28B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.24 |
| Trailing Annual Dividend Yield | 5.64 |
| Payout Ratio | 0.19 |
| Last Split Factor | N/A |
| Last Split Date | N/A |